𝔖 Bobbio Scriptorium

✦ LIBER ✦

Vatalanib (PTK787/ZK 222584) in Combination with FOLFOX4 Versus FOLFOX4 Alone as First-Line Treatment for Colorectal Cancer: Preliminary Results from the CONFIRM-1 Trial

✍ Scribed by Preeta Tyagi; Edward Chu; Vinay K. Jain

Book ID: 119616914
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 99 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.1016/s1533-0028(11)70162-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3010 ORAL Final overall survival (OS) re

3010 ORAL Final overall survival (OS) results of CONFIRM 1 (CF1), a randomized, double-blind, placebo-controlled phase III trial in patients with metastatic adenocarcinoma of the colon or rectum (mCRC) receiving first line chemotherapy with oxaliplatin/5-fluorouracil/Leucovorin (FOLFOX 4) and PTK787/ZK 222584 (PTK/ZK) or placebo (PBO)

✍ J.R. Hecht; T. Trarbach; E. Jaeger; J. Hainsworth; R.A. Wolff; K. Lloyd; G. Bodo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB